Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Kitzis

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study]C J Soussy, C Morel, M D Kitzis, et al.
Pathologie-Biologie|June 1, 1983
[In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study]L Deforges, J Le Van Thoi, C J Soussy, et al.
Pathologie-Biologie|May 1, 1984
[Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study]C Quentin, J Auzerie, C Bebear, et al.
Pathologie-Biologie|April 1, 1996
[In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve]C J Soussy, M Cluzel, E Derlot, et al.
International Journal of Antimicrobial Agents|February 8, 2011
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpointsC Lascols, P Legrand, A Mérens, et al.
Pathologie-Biologie|June 1, 1983
[In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study]C J Soussy, J Le Van Thoi, M Chanal, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 20, 2010
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpointsC Lascols, P Legrand, A Mérens, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study]C J Soussy, C Morel, M D Kitzis, et al.
Pathologie-Biologie|June 1, 1983
[In vitro activity of azthreonam on hospital Gram-negative bacilli. Results of a multicenter study]L Deforges, J Le Van Thoi, C J Soussy, et al.
Pathologie-Biologie|May 1, 1984
[Bacteriostatic activity of apalcillin on Gram-negative bacilli and strict anaerobic bacteria. Multicenter study]C Quentin, J Auzerie, C Bebear, et al.
Pathologie-Biologie|April 1, 1996
[In vitro antibacterial activity of a new fluoroquinolone, sparfloxacin, against nosocomial bacteria, and concordance curve]C J Soussy, M Cluzel, E Derlot, et al.
International Journal of Antimicrobial Agents|February 8, 2011
In vitro antibacterial activity of ceftobiprole against clinical isolates from French teaching hospitals: proposition of zone diameter breakpointsC Lascols, P Legrand, A Mérens, et al.
Pathologie-Biologie|June 1, 1983
[In vitro effect of rosoxacin on hospital bacteria. Results of a multicenter study]C J Soussy, J Le Van Thoi, M Chanal, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 20, 2010
In vitro antibacterial activity of doripenem against clinical isolates from French teaching hospitals: proposition of zone diameter breakpointsC Lascols, P Legrand, A Mérens, et al.
Pageof 9